Poly-ICLC, a multi-functional immune modulator for treating cancer - ScienceDirect
In situ Vaccination Followed by Intramuscular poly-ICLC Injections for the Treatment of Hepatocellular Carcinoma in Mouse Models - ScienceDirect
Cancers | Free Full-Text | Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events
Poly I:C as Vaccine Adjuvant - Creative Biolabs
Frontiers | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
Cytosolic Receptor Melanoma Differentiation–Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury | Stroke
Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners | SpringerLink
JCI - Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
HILTONOL
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration | Journal for ImmunoTherapy of Cancer
Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis | PLOS Pathogens
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques | PLOS Pathogens
JCI - Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma. - Abstract - Europe PMC
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice. - Abstract - Europe PMC
Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library
METHOD FOR PREPARATION OF POLY-ICLC AND USES THEREOF - Patent 1778186
Frontiers | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
poly ICLC | Semantic Scholar
Systemic administration of poly-ICLC elicits antitumor effects... | Download Scientific Diagram
Poly I:C as Vaccine Adjuvant - Creative Biolabs
